PT Metro Healthcare Indonesia Tbk (IDX:CARE)
Indonesia · Delayed Price · Currency is IDR 428.00
0.00 (0.00%)
Aug 12, 2026, 4:00 PM WIB
IDX:CARE Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 493,131 | 439,752 | 319,022 | 242,681 | 260,426 | 290,934 | |
Revenue Growth | 58.25% | 37.84% | 31.46% | -6.81% | -10.49% | 34.51% |
Cost of Revenue | 249,183 | 226,845 | 216,317 | 154,716 | 166,533 | 146,481 |
Gross Profit | 243,948 | 212,906 | 102,705 | 87,965 | 93,893 | 144,454 |
Selling, General & Admin | 138,486 | 132,207 | 124,652 | 115,939 | 145,618 | 120,302 |
Other Operating Expenses | 12,375 | 10,662 | 6,703 | 7,782 | 8,663 | 8,748 |
Operating Expenses | 150,882 | 142,890 | 132,633 | 124,104 | 154,484 | 130,356 |
Operating Income | 93,066 | 70,016 | -29,928 | -36,139 | -60,591 | 14,098 |
Interest Expense | -97,529 | -76,522 | -74,565 | -75,775 | -89,333 | -25,432 |
Interest & Investment Income | 15,323 | 15,555 | 6,243 | 6,623 | 31,785 | 15,782 |
Other Non Operating Income (Expenses) | -444.43 | -1,027 | -961.36 | -904.24 | -844.92 | -694.16 |
EBT Excluding Unusual Items | 10,416 | 8,021 | -99,212 | -106,195 | -118,984 | 3,754 |
Gain (Loss) on Sale of Assets | 49.84 | 49.84 | 23,448 | 72 | 25,668 | 76.36 |
Other Unusual Items | - | - | - | - | - | 2,676 |
Pretax Income | 10,465 | 8,071 | -75,764 | -106,123 | -93,316 | 6,507 |
Income Tax Expense | 4,108 | 2,926 | 4,153 | 4,566 | 288.46 | 332.91 |
Earnings From Continuing Operations | 6,358 | 5,146 | -79,917 | -110,689 | -93,604 | 6,174 |
Minority Interest in Earnings | -358.14 | -192.85 | -391.96 | -230.93 | 60.53 | -74.43 |
Net Income | 6,000 | 4,953 | -80,309 | -110,920 | -93,544 | 6,099 |
Net Income to Common | 6,000 | 4,953 | -80,309 | -110,920 | -93,544 | 6,099 |
Net Income Growth | - | - | - | - | - | -57.39% |
Shares Outstanding (Basic) | 33,250 | 33,250 | 33,250 | 33,250 | 33,250 | 33,250 |
Shares Outstanding (Diluted) | 33,250 | 33,250 | 33,250 | 33,250 | 33,250 | 33,250 |
Shares Change | - | - | - | - | - | 17.70% |
EPS (Basic) | 0.18 | 0.15 | -2.42 | -3.34 | -2.81 | 0.18 |
EPS (Diluted) | 0.18 | 0.15 | -2.42 | -3.34 | -2.81 | 0.18 |
EPS Growth | - | - | - | - | - | -63.80% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -172,792 | -164,870 | -339,941 | -95,595 | -339,291 | -263,276 |
Free Cash Flow Per Share | -5.20 | -4.96 | -10.22 | -2.88 | -10.20 | -7.92 |
Gross Margin | 49.47% | 48.41% | 32.19% | 36.25% | 36.05% | 49.65% |
Operating Margin | 18.87% | 15.92% | -9.38% | -14.89% | -23.27% | 4.85% |
Profit Margin | 1.22% | 1.13% | -25.17% | -45.71% | -35.92% | 2.10% |
Free Cash Flow Margin | -35.04% | -37.49% | -106.56% | -39.39% | -130.28% | -90.49% |
EBITDA | 120,327 | 96,342 | -4,412 | -14,554 | -37,714 | 31,395 |
EBITDA Margin | 24.40% | 21.91% | -1.38% | -6.00% | -14.48% | 10.79% |
D&A For EBITDA | 27,261 | 26,326 | 25,516 | 21,585 | 22,878 | 17,297 |
EBIT | 93,066 | 70,016 | -29,928 | -36,139 | -60,591 | 14,098 |
EBIT Margin | 18.87% | 15.92% | -9.38% | -14.89% | -23.27% | 4.85% |
Effective Tax Rate | 39.25% | 36.25% | - | - | - | 5.12% |
Advertising Expenses | - | 556.44 | 490.32 | 332.36 | 621.1 | 204.18 |